InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Reumuth Mary, 首席财务官. Director active across 2 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 15 reports have been logged. Split: 0 buy · 10 sells. Total volume traded: €105k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 22 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reumuth Mary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
32,230 股@ US$0.8331.4% 占其流量Common StockSEC:0001710969-25-000003:0
3,631 股@ US$4.0124.9% 占其流量Common StockSEC:0001415889-25-018320:0
2,850 股@ US$3.7424.7% 占其流量Common StockSEC:0001415889-25-015680:0
10,100 股0Common StockSEC:0001415889-25-001059:0
4,163 股@ US$4.7564.8% 占其流量Common StockSEC:0001415889-24-018375:0
1,786 股@ US$6.0935.2% 占其流量Common StockSEC:0001415889-24-015224:0
4,600 股0Common StockSEC:0001415889-24-000767:0
36,144 股0Common StockSEC:0001415889-23-010285:0
14,736 股Common StockSEC:0001415889-23-009136:0
9,525 股0Common StockSEC:0001415889-23-000639:0
194 股@ US$6.512.0% 占其流量Common StockSEC:0001415889-22-010880:0
2,613 股@ US$0.370.0059% mcap1.5% 占其流量Common StockSEC:0001415889-22-007062:0
2,850 股@ US$1.3010.3% 占其流量Common StockSEC:0001415889-22-000405:0
9,449 股@ US$1.8045.9% 占其流量Common StockSEC:0001415889-21-005012:0
2,452 股@ US$5.7737.1% 占其流量Common StockSEC:0001415889-21-003259:0
15 条申报中的 15 条
About Reumuth Mary
Reumuth Mary is Directeur Financier at Kala Pharmaceuticals, Inc. and KALA BIO, Inc. She has made 15 filings in total, and across the recent sample of 15 filings between 2021-06-29 and 2025-10-24, the reported transactions are all sales for a total of EUR 105467.
